DY
Therapeutic Areas
Perseo Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PER301 | Exocrine Pancreatic Insufficiency (EPI) | Preclinical |
| PER302 | Acquired Lactase Deficiency (ALD) | Preclinical |
| PER303 | Phenylketonuria (PKU) | Preclinical |
| PER312 | Congenital Sucrase-Isomaltase Deficiency (CSID) | Preclinical |
| PER304 | Maple Syrup Urine Disease (MSUD) | Preclinical |
| PER200 | Lysosomal Storage Diseases | Research |